Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News CorMedix Inc CRMD

Healthcare
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CRMD)

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

GlobeNewswire 9 hours ago

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

GlobeNewswire November 4, 2024

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

GlobeNewswire October 30, 2024

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

GlobeNewswire October 24, 2024

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

GlobeNewswire October 23, 2024

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

GlobeNewswire October 8, 2024

CorMedix Inc. Announces New Commercial Agreement

GlobeNewswire September 19, 2024

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

GlobeNewswire September 13, 2024

CorMedix Inc. Announces New Commercial Agreement

GlobeNewswire September 9, 2024
View More News ››

Opinion & Analysis (NDAQ:CRMD)

Interim Readout for Pharma Trial 'Delivers Home Run'

Streetwise Reports August 2, 2018

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016

CorMedix Transformative Anti-Infective Technology for Catheters Developed to Decrease Serious Drug-Resistant Infections: CEO Randy Milby

The Life Sciences Report February 11, 2016
View More Opinion ››

Bullboard Posts (NDAQ:CRMD)

CorMedix Inc. to Report Third Quarter 2024 Financial Results

JUST IN: $CRMD CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024BERKELEY...
whytestocks - October 23, 2024

CorMedix Inc. Reports Second Quarter and Six Month 2024 Fina

Just In: $CRMD CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business UpdateBERKELEY HEIGHTS, N...
whytestocks - August 14, 2024

Fda approuved

Ggghjhdsfyjjfv
Nibinator - November 15, 2023

FDA news

Doesn't seem to be anyone here anymore. I thought that was pretty favourable FDA news this morning yet after an intial surge here...
Pandora - July 9, 2019

RE:1-5 reverse split

Well the one for five has happened this morning and as per normal the first direction is down. There is so much more room in that...
Pandora - March 26, 2019

RE:1-5 reverse split

That is correct -- one new share for every five shares you currently own. If one existing share is $1.80 a new share will be $1.80 x 5...
Pandora - March 15, 2019
View more Bullboard ››

Nanalysis Scientific Corp.

Nanalysis Scientific Corp.

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for ...
View More »